Industry Insights

Heightened Scrutiny for Telehealth Companies: Lessons from Eli Lilly’s Recent Lawsuits Against Telehealth Organizations

Four recent lawsuits filed by Eli Lilly against Fella Health, Mochi Health, Willow Health and Henry Meds offer critical insights for telehealth companies operating in an increasingly scrutinized industry.

Our new article breaks down the claims, explores potential defenses, and examines the broader implications for the telehealth sector—highlighting key takeaways for industry stakeholders. Read here.

Providers Beware: The Challenges of Practicing Behavioral Health Care

Behavioral health professionals face a growing list of challenges—from workforce shortages and stigma to policy hurdles, burnout, and low reimbursement rates. As demand rises, so does the complexity of practicing in this space.

Our latest article explores the most pressing issues facing behavioral health care providers and why legal support is more important than ever. Read here.

Provider Alert: False Claims Act Case Targets Alleged Improper Radiopharmaceutical Practices in Cardiology Testing

A federal case out of D.C. alleges over 500 doctors nationwide overbilled Medicare for radiopharmaceuticals. While 16 cardiology practices already settled for $17.7M in late 2024, a Second Amended Complaint now targets individual physicians for alleged False Claims Act violations.

For more information on this case and insights into how your practice can remain compliant, read the article here.

Updated Guidance on New York’s Health Care Transaction Law – What You Need to Know

The New York State Department of Health recently issued FAQs clarifying reporting rules under Public Health Law Article 45-A. If you're a healthcare entity engaging in $25M+ transactions, you may need to notify the DOH 30 days pre-closing.

Explore key takeaways from the FAQs and insights for healthcare entities in New York here.

Structuring Captive Practice Models for MSOs

In light of an increase in regulatory scrutiny, it is essential to properly structure Captive Practice arrangements to minimize legal exposure.

Our latest article breaks down the risks of Captive Practice models and safeguards your business can implement to ensure compliance with regulatory requirements. Read here.

Healthcare M&A: Key Consideration for Prospective Sellers

As private equity interest in physician practices and other healthcare businesses accelerates, prospective sellers must navigate a myriad of complex legal and business issues. 

Our new article outlines key considerations for prospective sellers looking to position their business for a successful transaction. Read here.

New Jersey’s Step Therapy Reform: What A1825 Means for New Jersey Hospitals

Starting January 1, 2026, New Jersey’s new step therapy law (A1825) will introduce key changes for hospitals and providers participating in NJ-regulated health plans—including NJ FamilyCare, SHBP, and SEHBP.

Read our latest article on what A1825 means for New Jersey hospitals and how your team can get ahead of the changes. Read here.

On-Demand Webinars

"Navigating GLP-1 Compounding" Webinar Series

Stay ahead of the curve with our 3 part webinar series navigating the evolving regulatory landscape for GLP-1 compounding.

Click the image below to access the webinars:

"Navigating Wound Care – Strategies for Compliance and Defense"

As regulatory scrutiny around wound care intensifies, healthcare providers are under growing pressure to maintain compliance while ensuring quality care. In this essential webinar, Frier Levitt partners guide you through the evolving legal landscape and offer practical strategies to protect your practice.

Click the image below to access the webinar:

Subscribe to our YouTube:

Newsworthy

Frier Levitt Successfully Reverses Ten-Year Medicare Reenrollment Bar for DMEPOS Supplier

Frier Levitt Successfully Reversed Medicare Application Denial

Frier Levitt Successfully Advocates for Healthcare Suppliers Navigating Medicare Enrollment Issues

Arielle Miliambro Featured in Axios on GLP-1 Compounding Developments

At Frier Levitt, we understand the complex regulatory and transactional landscape that wound care providers and businesses face. Our team of experienced healthcare attorneys is dedicated to helping wound care professionals, including mobile wound care providers, navigate state and federal regulatory compliance, business transactions, and payment audits by third-party payors.

By partnering with knowledgeable legal counsel, wound care practices can develop strategies to mitigate risk, enhance compliance, and position themselves for sustainable growth in this dynamic healthcare sector. If you are a wound care provider or entrepreneur looking for legal guidance, contact us today to schedule a consultation and learn how we can help protect and grow your practice.

For more information on Frier Levitt’s Wound Care practice group, click HERE.

Very truly yours,

Daniel B. Frier, Esq.

Co-Founding Partner

Frier Levitt

dbfrier@frierlevitt.com

973.618.1660

Bio | LinkedIn

© 2025 Frier Levitt. All rights reserved. ATTORNEY ADVERTISING.

The contents of this newsletter and all related communications do not constitute legal advice or an attorney-client relationship. Publication contents are for general information purposes and are not intended to be a substitute for legal advice. You should seek legal advice or other professional advice in relation to any particular questions that you or your organization may have.